Sangel Biomedical Venture Capital is a Shenzen based venture capital firm investing in biotechnology companies in China and abroad. It was established in 2010 to support high-tech enterprises in China and western countries. The company focuses on biomedicine, medical devices, healthcare, pharmaceutical, and livelihood security. In 2015, Sangel started its first international subsidiary, Sangel Venture Capital Corp in Chicago, United States. As of 2019, the company has made 16 investments in 15 portfolio companies with one successful exit.